Answers are grounded in this paper and cite their sources.
The current results indicated that measuring plasma proteasome activity has prognostic value in CLL that, when combined with B2M, can be independent of IgVH mutation status.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: